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Abstract
Among coagulase-positive staphylococci of animal origin, the members of the Staphylococcus intermedius-group (SIG: S. intermedius,
Staphylococcus pseudintermedius and Staphylococcus delphini) are important opportunistic pathogens in different animal hosts and occasionally
in humans. However, the unambiguous species diagnosis of SIG is often challenging. Therefore, matrix-assisted laser desorption ionization—
time of ﬂight mass spectrometry (MALDI-TOF MS) -based SIG-identiﬁcation with Bruker Microﬂex LT in combination with BIOTYPER 3.0
software (Bruker Daltonics, Bremen, Germany) was evaluated using (i) the original database content and (ii) the database after extension
with distinct hierarchical clustered reference spectra for 60 SIG. A convenience sample comprising 200 isolates was used to compare both
database performances. As a result, 17 isolates initially diagnosed as S. intermedius with the current content of the Bruker database were
identiﬁed as S. pseudintermedius by applying the in-house reference spectra extended version. Furthermore, a signiﬁcant improvement
(average rise of log score value: 0.24) of the SIG identiﬁcation score values was achieved, emphasizing that further sequence-based
reﬁnement of the Bruker database content allows improvement of MALDI-TOF MS-based identiﬁcation.
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Introduction
Coagulase-positive staphylococci (CPS) are considered as
typical opportunistic pathogens and capable of causing a wide
range of different purulent and toxin-mediated diseases in
humans and animals. While Staphylococcus aureus is the
predominant CPS species associated with staphylococcal
diseases in humans, Staphylococcus pseudintermedius seems to
have a similar importance for dogs [1,2]. Further, a rise in
reports on methicillin-resistant S. pseudintermedius (MRSP),
which were frequently associated with multidrug resistance, is
a major concern in veterinary medicine, highlighting the need
for reliable and fast identiﬁcation of these bacteria [1,3–7]. In
recent years, gene-based approaches have shown that CPS
phenotypically identiﬁed as Staphylococcus intermedius belong to
three closely related but distinct species, namely S. intermedius,
Staphylococcus delphini and S. pseudintermedius, which represent
the Staphylococcus intermedius-group (SIG) [8]. These results
suggest that most canine isolates previously identiﬁed as
S. intermedius should have been classiﬁed as S. pseudintermedius
[9]. At present, classical biochemical differentiation between
the members of the SIG is at the least complex and may result
in unreliable or insufﬁcient species identiﬁcation [10]. A
reliable method to discriminate S. pseudintermedius from other
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SIG members and S. aureus by demonstrating a certain MboI
restriction site of the housekeeping gene pta was published in
2009 [11]. However, this approach is time-consuming and not
suitable for ‘high throughput’ laboratories.
Other methods, such as intact protein proﬁling through
matrix-assisted laser desorption ionization—time of ﬂight
mass spectrometry (MALDI-TOF MS) have been used to
demonstrate the possibility of rapid differentiation of SIG [12].
This was achieved using a commercial software tool, Ax-
ima-Assurance-Shimadzu/SARAMIS-AnagnosTec (now
renamed as VITEK MS) (bioMerieux, N€urtingen, Germany).
However, the Bruker BIOTYPER database has not been evaluated
for differentiation of the SIG yet. Our aim was to reﬁne the
BIOTYPER database by including additional SIG strains, which
were identiﬁed by sequence-based methods [8]. In order to
test the reliability and advantage of the additional database
content, 200 putative SIG isolates formerly diagnosed by
biochemical methods obtained from various sources and hosts
were investigated by MALDI-TOF MS and the resulting spectra
were analysed twice: First using the current Bruker database
content and afterwards with the reﬁned in-house database.
Materials and Methods
Selection of CPS strains for the MALDI-TOF MS spectra
library
To build up a reliable reference database for spectra associated
with the different members of the SIG, S. pseudintermedius
(n = 43, including 20 MRSP), S. intermedius (n = 5) and S. del-
phini (n = 12) that originated from different sources (see
Table 1) were initially selected. Unambiguous species identity
of each strain was demonstrated by partial sequencing of the
genes pta, cpn60, tuf and 16S rRNA according to previously
published methods [8] (Table 1). The obtained sequences
were concatenated and based on the corresponding alignment
a clustering was performed using unweighted pair group
method with arithmetic mean with GENEIOUS R7 (Biomatters,
Auckland, New Zealand).
Other CPS such as S. aureus (n = 8) and Staphylococcus
schleiferi ssp. coagulans (n = 2) were included as control strains.
Species veriﬁcation of S. aureus was demonstrated by PCR [13]
and S. schleiferi ssp. coagulans was veriﬁed by sequencing
1100 bp of 16S rRNA gene [14].
Protein extraction and MALDI-TOF MS measurements
The protein extraction as well as the MALDI-TOF MS
measurements on a Microﬂex LT instrument using FLEXCON-
TROL 3.0 software (Bruker Daltonics, Leipzig, Germany) were
carried out as described in Murugaiyan et al. [15], with minor
modiﬁcations. In brief, each SIG isolate was cultured on M€uller
Hinton agar with 5% sheep blood (Becton Dickinson, Heidel-
berg, Germany) and extracted using a standard formic acid/
acetonitrile procedure. The samples were spotted on the
‘MicroScout Target’ plate (Bruker Daltonics, Bremen, Ger-
many) using saturated a-cyano-4-hydroxycinnamic acid matrix
solution. Measurements were carried out in a range of 2000–
20 000 m/z with the following instrument parameters: ion
source 1 at 20 kV, ion source 2 at 16.3 kV, lens at 7 kV,
extraction delay time of 200 ns, initial laser power of 30%,
maximum laser power of 40%, and laser attenuation offset of
38% (range, 30%).
Spectral analysis and reference spectra
A total of 27 spectra were acquired for each investigated
isolate (60 SIG and ten other CPS), evaluated and the
reference spectra were created using BIOTYPER 3.0 software
(Bruker Daltonics) as described recently by Murugaiyan, et al.,
[15]. These created references were then assigned to their
respective nodes on the taxonomy tree of the Bruker BIOTYPER
database using a library of 4613 entries (January 2014).
Cluster analysis and SIG discrimination
The discriminative power for SIG was evaluated by comput-
ing the MALDI-TOF MS reference spectra dendrogram based
on elucidation distance measurement and the average-linkage
algorithm settings of the BIOTYPER 3.0 software. The resulting
dendrogram was compared with the phylogenetic tree
obtained from the sequences of pta, cpn60, tuf and 16S
rRNA gene.
Evaluation of the SIG database using 200 staphylococcal
isolates
A convenience sample consisting of 193 clinical CPS strains and
seven strains from the culture collection of the University of
G€oteborg (CCUG; see Supporting information, Table S1)
represents a broad range of clinical infection sites, hosts and
geographic origins since the year 2000. The clinical strains
were previously diagnosed as described by Bannerman and
Peacock [16] or by using the automated Vitek2 system
(bioMerieux, N€urtingen, Germany) following the manufac-
turer’s instructions.
Overnight cultures were directly transferred on a MAL-
DI-TOF MS target plate, overlaid with saturated a-cyano-4-hy-
droxycinnamic acid, air dried and subjected to MALDI-TOF
MS identiﬁcation. The identiﬁcation was carried out following
the recommendations of the Bruker system, with identiﬁcation
log (score) values ranging from 0 to 3. A result associated with
score values from 0 to 1.699 indicates ‘no reliable identiﬁca-
tion’ (NRI); score values from 1.7 to 1.999 indicate a ‘probable
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genus identiﬁcation’ (PGI); score values from 2.0 to 2.299
indicate a ‘secure genus identiﬁcation and probable species
identiﬁcation’ (PSI), and score values from 2.300 to 3.000
indicate a ‘highly probable species identiﬁcation’ (SI).
The score values of each isolate were recorded twice: (i)
using the original Bruker database and (ii) after supplementa-
tion of 60 SIG reference spectra. The resulting differences
between the score values from measurements (i) and (ii) were
TABLE 1. List of well-deﬁned staphylococcal strains included for the creation of a main spectral library for improvement of the
distinction among the members of the Staphylococcus intermedius group
S. No Staphylococcal species ID Host mecAa Origin Reference
1 Staphylococcus pseudintermediusb BF138202 Dog pos. France [6]
2 S. pseudintermediusb BF138203 Cat pos. France [6]
3 S. pseudintermediusb CCUG32915 Dog neg. Sweden 
4 S. pseudintermediusb IMT10762 Dog pos. Germany [6]
5 S. pseudintermediusb IMT11384 Dog pos. Germany [6]
6 S. pseudintermediusb IMT11897 Dog pos. Germany [6]
7 S. pseudintermediusb IMT12531 Dog pos. Germany [6]
8 S. pseudintermediusb IMT12559 Dog pos. Germany [6]
9 S. pseudintermediusb IMT14052 Horse pos. Germany [6]
10 S. pseudintermediusb IMT14529 Dog pos. Germany [6]
11 S. pseudintermediusb IMT14532 Dog pos. Germany [6]
12 S. pseudintermediusb IMT17831 Human neg. Germany #
13 S. pseudintermediusb IMT17931 Human neg. Germany #
14 S. pseudintermediusb IMT17932 Human pos. Germany #
15 S. pseudintermediusb IMT18786 Dog neg. Germany [7]
16 S. pseudintermediusb IMT18789 Dog neg. Germany [7]
17 S. pseudintermediusb IMT18796 Dog neg. Germany [7]
18 S. pseudintermediusb IMT18797 Human neg. Germany [7]
19 S. pseudintermediusb IMT18798 Dog neg. Germany [7]
20 S. pseudintermediusb IMT18799 Dog neg. Germany [7]
21 S. pseudintermediusb IMT18802 Dog neg. Germany [7]
22 S. pseudintermediusb IMT18807 Dog neg. Germany [7]
23 S. pseudintermediusb IMT18810 Dog neg. Germany [7]
24 S. pseudintermediusb IMT18827 Dog neg. Germany [7]
25 S. pseudintermediusb IMT18828 Human neg. Germany [7]
26 S. pseudintermediusb IMT18875 Dog neg. Germany [7]
27 S. pseudintermediusb IMT18878 Human neg. Germany [7]
28 S. pseudintermediusb IMT18880 Dog neg. Germany [7]
29 S. pseudintermediusb IMT18883 Human neg. Germany [7]
30 S. pseudintermediusb IMT18884 Dog neg. Germany [7]
31 S. pseudintermediusb IMT18885 Human pos. Germany [7]
32 S. pseudintermediusb IMT18889 Dog neg. Germany [7]
33 S. pseudintermediusb IMT18914 Human neg. Germany [7]
34 S. pseudintermediusb IMT18915 Dog neg. Germany [7]
35 S. pseudintermediusb IMT21837 Dog neg. Germany [7]
36 S. pseudintermediusb VB969052 Dog pos. Austria [6]
37 S. pseudintermediusb VB969149 Dog pos. Germany [6]
38 S. pseudintermediusb VB971162 Cat pos. Italy [6]
39 S. pseudintermediusb VB971904 Dog pos. the Netherlands [6]
40 S. pseudintermediusb VB973750.1 Dog pos. Luxembourg [6]
41 S. pseudintermediusb VB974532 Cat pos. Germany [6]
42 S. pseudintermediusb VB976346.3 Dog pos. the Netherlands [6]
43 S. pseudintermediusb VB976771.2 Dog pos. Italy [6]
44 Staphylococcus delphinib BF136161.2 Horse neg. France #
45 S. delphinib CCUG30107 Dolphin neg. Italy 
46 S. delphinib CCUG38984 Unknown neg. Unknown 
47 S. delphinib CCUG51769 Mink neg. Czech Republic 
48 S. delphinib VB 978908.2 Horse neg. Germany #
49 S. delphinib VB958847 Horse neg. Germany #
50 S. delphinib VB959563 Horse neg. the Netherlands #
51 S. delphinib VB961094 Horse neg. Germany #
52 S. delphinib VB969765 Horse neg. Germany #
53 S. delphinib VB969967.1 Horse neg. Germany #
54 S. delphinib VB972946 Pigeon neg. Germany #
55 S. delphinib VB975519 Horse neg. Germany #
56 Staphylococcus intermediusb NCTC 11048 Pigeon neg. Czech Republic [8]
57 S. intermediusb P-2A Pigeon neg. Japan [8]
58 S. intermediusb P-45A Pigeon neg. Japan [8]
59 S. intermediusb P-53 Pigeon neg. Japan [8]
60 S. intermediusb VB963312 Pigeon neg. Germany #
61 Staphylococcus aureusa IMT29002 Cat pos. Germany #
62 S. aureusa IMT29172 Dog neg. Germany #
63 S. aureusa IMT29325 Horse neg. Germany #
64 S. aureusa NCTC 8325 Lab. strain neg. Unknown #
65 S. aureusa VB 973156.2 Seal pos. the Netherlands #
66 S. aureusa VB 978536 Dolphin pos. Italy #
67 S. aureusa VB 978537 Dolphin pos. Italy #
68 S. aureusa VB965944.1 Pig neg. Germany #
69 Staphylococcus schleiferi ssp. coagulansc CCUG37248 Dog neg. Japan 
70 S. schleiferi ssp. coagulansc VB993188 Dog neg. Finland #
CCUG, Culture Collection, University of G€oteborg; pos., positive; neg.: negative; #, present study; , CCUG/present study.
aPCR according to Merlino et al. 2002 [13].
bPartial sequencing of pta, cpn60, 16S rRNA, tuf according to Bannoehr et al. 2007 [8].
c16S rRNA sequencing; primers according to Turner et al. (1999) [14].
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visualized and statistically analysed using IBM SPSS 21 (Heidel-
berg, Germany) and the non-parametric Wilcoxon test (paired
data). Results were considered signiﬁcant at p <0.05.
Results
This study was initiated to evaluate and reﬁne the BIOTYPER 3.0
reference database (Bruker Daltonics) with additional spectra
speciﬁc for each of the species composing the SIG. To create a
reliable reference spectra library containing the most repro-
ducible peaks, 27 spectra were acquired for each individual
strain. The FLEXCONTROL software was used to display
differences in peak pattern and Fig. 1 shows representative
examples of the raw ﬁngerprint spectra obtained for S. inter-
medius, S. pseudintermedius and S. delphini. The spectra pat-
terns of strains belonging to the same species displayed a
similar peak pattern, while differences within the peak
intensities occurred among the technical replicates.
Identiﬁcation rates for the Bruker BIOTYPER 3.0 database
before and after additional SIG reference spectra
supplementation
The score values achieved for the 200 clinical isolates before
(i) and after (ii) the inclusion of additional reference spectra for
the distinct SIG members of the Bruker BIOTYPER database 3.0
content are presented in Table 2 and the Supporting infor-
mation, Table S1. Efﬁcacy of approach (ii) was shown by a
graphical representation (Fig. 2), wherein the average score
value appeared to be improved by 0.237. Notably, score values
for seven isolates identiﬁed as S. delphini remained unchanged
(Table S1). Furthermore, the p-value (p <0.001) indicated a
signiﬁcant discriminatory improvement for procedure (ii).
Within the ﬁrst approach, three isolates were identiﬁed at
the SI (1.5%) level and 170 (85%) at the PSI level, while 25
isolates showed score values only associated with the baseline
PGI level. For two isolates no reliable identiﬁcation (NRI) was
achieved. Notably, S. intermedius appeared to be the sec-
ond-best hit for 29 (22 on PSI and seven on PGI level) out of
162 isolates whose ﬁrst-best hit was S. pseudintermedius.
Following inclusion of the new in-house reference spectra
(ii), only seven isolates (3.5%) were identiﬁed at the baseline
PGI and none on the NRI level, while 36 (18%) were identiﬁed
at the PSI and 175 (78.5%) at the SI level. In addition, 17
isolates that were formerly identiﬁed (approach (i)) as
S. intermedius on the levels of either PGI (n = 4) or PSI
(n = 13) were assigned as S. pseudintermedius (ﬁve on PSI and
12 on SI level) in the second measurement (ii).
Dendrograms
The discriminatory abilities of the supplemented protein
signature proﬁle library of the BIOTYPER 3.0 for the individual
SIG members is shown by a tree based on MALDI-TOF MS
results (Fig. 3a). The S. aureus and S. schleiferi ssp. coagulans
strains that were used as out-groups cluster clearly apart from




FIG. 1. A zoomed view (range from
2000 to 10 500 m/z) of representative
matrix-assisted laser desorption ionization
—time of ﬂight mass spectra obtained for
the distinct members of the Staphylococcus
intermedius group (SIG): Staphylococcus
delphini (a), Staphylococcus intermedius (b)
and Staphylococcus pseudintermedius (c).
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clustering within the SIG clearly differentiates S. intermedius,
S. delphini and S. pseudintermedius.
The sequence-based clustering shows a similar result
(Fig. 3b). All SIG members are uniquely assigned to one group
according to the species to which they belong.
Discussion
Supplementation of the original BIOTYPER 3.0 spectra library
with distinct reference spectra for S. intermedius, S. pseudinter-
medius and S. delphini created during this study was evaluated
using 200 SIG representing a broad spectrum of different
hosts, years, geographic origins and infected or colonized body
sites. In contrast to the limited performance of the original
database content (see Results), the improvement of the
reference spectra library allowed rapid species identiﬁcation
for 78.5% of the investigated samples at the best identiﬁcation
level (SI), while a further 36 isolates (18%) were identiﬁed at
the second best (PSI) and only seven isolates (3.5%) were
assigned at a baseline PGI level. A highly signiﬁcant p-value
(p <0.001) also conﬁrms the discriminatory power for differ-
entiation among SIG after supplementation of the original
database. This outcome underscores that the improvement of
the reference spectra database could be achieved by including
SIG strains associated with an unambiguous species identity
originating from various geographical origins, hosts and body
sites.
In contrast to the study results by Decristophoris et al.,
score values obtained for all 19 S. delphini isolates (including
seven strains with unchanged score results) did not indicate a
high heterogeneity within the clinical strains investigated here
[12]. However, the average improvement of score values for
the S. delphini strains was 0.120 and therefore slightly below
TABLE 2. Score values and identiﬁcation matches obtained for 200 clinical Staphylococcus intermedius group isolates before (i)
and after (ii) augmentation of in-house reference spectra with Bruker BIOTYPER database 3.0.
Species
Matching with Bruker database Matching after inclusion of in-house references
n Cut-off log score value n Cut-off log score value
1.7–1.99 2.0–2.29 2.3–3.0 1.7–1.99 2.0–2.29 2.3–3.0
Staphylococcus delphini 19 (9.5%) 4 (2%) 12 (6%) 3 (1.5%) 19 (9.5) 4 (2%) 8 (4%) 7 (3.5%)
Staphylococcus intermedius 17 (8.5%) 4 (2%) 13 (6.5%) 0 0 0 0 0
Staphylococcus pseudintermedius 162 (81%) 17 (8.5%) 145 (72.5%) 0 181 (90.5%) 3 (1.5%) 28 (14%) 150 (75%)
Not identiﬁed 2 (1%) 0
Total 200 25 (12.5%) 170 (85%) 3 (1.5%) 200 7 (3.5%) 36 (18%) 157 (78.5%)
A result associated with score values from 0 to 1.699 indicates ‘no reliable identiﬁcation’ (NRI); score values from 1.700 to 1.999 indicate a ‘probable genus identiﬁcation’ (PGI);
score values from 2.000 to 2.299 indicate a ‘secure genus identiﬁcation and probable species identiﬁcation’ (PSI), and score values from 2.300 to 3.000 indicate a ‘highly probable
species identiﬁcation’ (SI)
FIG. 2. Graphical representation of the score values obtained for 200 Staphylococcus intermedius group (SIG) isolates before and after reﬁnement (ii)
of the BIOTYPER 3.0 database with reference spectra for 60 SIG together with ten other coagulase-positive staphylococci (= 70 spectra). Circles
indicate the score values achieved by applying the manufacturer’s version of the database (approach (i), see Materials and Methods for further
explanation) and the diamonds represent the score values reached in the second measurement (ii), associated with a rise of the average value score
of 0.24.
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the overall improvement of 0.237. Moreover, 17 isolates that
were initially identiﬁed as S. intermedius (= best match) using
the original BIOTYPER 3.0 spectra library were clearly recog-
nized as S. pseudintermedius by use of the supplemented data
base. Consequently, a higher average score value improvement
for the distinction between S. intermedius and S. pseudinterme-
dius seems to be reasonable.
In total, 60 methicillin-resistant (n = 20) and methicililn-sus-
ceptible (n = 40) SIG strains representing a broad spectrum of
different hosts and geographical origins that includes well-char-
acterized European isolates from earlier studies published by
our group [6,7] were chosen to set up the reference spectra
library (Table 1). However, this study might be limited to
some degree by the relatively small S. intermedius sample
number available from different sources for MALDI-TOF MS
and sequence data evaluation.
At present, only a limited number of methods for accurate
and rapid differentiation among staphylococci of the interme-
dius-group (SIG) are available [1]. In recent years, MALDI-TOF
MS-based microbial species identiﬁcation emerged as a rapid
method of choice and has been used in identiﬁcation of a
variety of Staphylococcus species [17–20]. The reclassiﬁcation
of the Listeria CAMP test strain S. aureus ATCC 49444 as
S. pseudintermedius highlights the possibility of identiﬁcation
confusion among CPS, including S. aureus [7]. Further, the
advent of modern gene-based molecular techniques resulted in
revision of the taxonomy of many bacterial species, including
the closely related members of the SIG [8,21, 22]. Recently,
one of two frequently used commercial software tools,
SARAMISTM (Spectral Archive and Microbial Identiﬁcation
System, AnagnosTec GmbH, Zossen, Germany), was used to
demonstrate the possibility of MALDI-TOF MS-based rapid
discrimination among the species composing the SIG [12].
While Staphylococcus species identiﬁcation has been evaluated
with both frequently used software tools, SARAMISTM and
BIOTYPER (Bruker Daltonics) [23], the capacity of the BIOTYPER
3.0 software for differentiation among SIG has not been
demonstrated. Furthermore, due to the fact that CPS originally
identiﬁed as ‘S. intermedius’ turned out to be ‘S. pseudinterme-
dius’ in the recent past [8,10,22], the aim of this study was to
create additional and reliable reference spectra using
well-characterized SIG. In recent years, some reports on
severe clinical infections with S. pseudintermedius or other SIG
(including multidrug-resistant MRSP) in humans were recorded
(a) (b)
FIG. 3. Comparison of (a) score-oriented dendrogram of matrix-assisted laser desorption ionization—time of ﬂight mass spectral proﬁles
generated using BIOTYPER 3.0 software and (b) unweighted pair group method with arithmetic mean based tree calculated from the distances of the
sequences of the four housekeeping genes pta, cpn60, tuf and 16S rRNA.
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and recently reviewed [24]. The lack of CPS differentiation
from specimens of human origin may lead to underestimation
of the real prevalence and incidence of S. pseudintermedius (and
MRSP) in the human population [25]. Hence, unambiguous and
fast identiﬁcation of SIG by use of MALDI-TOF MS is a
powerful tool not only for daily laboratory routine but also to
investigate the impact and zoonotic behaviour of S. pseudin-
termedius in the future.
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